The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Azithromycin and the Risk of Cardiovascular Death
Open accessAbstract
BACKGROUND: Although several macrolide antibiotics are proarrhythmic and associated with an increased risk of sudden cardiac death, azithromycin is thought to have minimal cardiotoxicity. However, published reports of arrhythmias suggest that azithromycin may increase the risk of cardiovascular death. METHODS: We studied a Tennessee Medicaid cohort designed to detect an increased risk of death related to short-term cardiac effects of medication, excluding patients with serious noncardiovascular illness and person-time during and shortly after hospitalization. The cohort included patients who took azithromycin (347,795 prescriptions), propensity-score-matched persons who took no antibiotics (1,391,180 control periods), and patients who took amoxicillin (1,348,672 prescriptions), ciprofloxacin (264,626 prescriptions), or levofloxacin (193,906 prescriptions). RESULTS: During 5 days of therapy, patients taking azithromycin, as compared with those who took no antibiotics, had an increased risk of cardiovascular death (hazard ratio, 2.88; 95% confidence interval [CI], 1.79 to 4.63; P<0.001) and death from any cause (hazard ratio, 1.85; 95% CI, 1.25 to 2.75; P=0.002). Patients who took amoxicillin had no increase in the risk of death during this period. Relative to amoxicillin, azithromycin was associated with an increased risk of cardiovascular death (hazard ratio, 2.49; 95% CI, 1.38 to 4.50; P=0.002) and death from any cause (hazard ratio, 2.02; 95% CI, 1.24 to 3.30; P=0.005), with an estimated 47 additional cardiovascular deaths per 1 million courses; patients in the highest decile of risk for cardiovascular disease had an estimated 245 additional cardiovascular deaths per 1 million courses. The risk of cardiovascular death was significantly greater with azithromycin than with ciprofloxacin but did not differ significantly from that with levofloxacin. CONCLUSIONS: During 5 days of azithromycin therapy, there was a small absolute increase in cardiovascular deaths, which was most pronounced among patients with a high baseline risk of cardiovascular disease. (Funded by the National Heart, Lung, and Blood Institute and the Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
The pharmacokinetics of azithromycin in human serum and tissues
Foulds, G., Shepard, R. M., & Johnson, R. B. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.suppl_a.73 · Cited by 755
Indications for propensity scores and review of their use in pharmacoepidemiology
Glynn, R. J., Schneeweiss, S., & Stürmer, T. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_293.x · Cited by 541
Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes
Ray, W. A., Murray, K. T., Meredith, S., Narasimhulu, S. S., Hall, K., & Stein, C. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040582 · Cited by 496
Self-citationKannankeril, P., Roden, D. M., & Darbar, D. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003723 · Cited by 440
Recall Accuracy for Prescription Medications: Self-report Compared with Database Information
West, S. L., Savitz, D. A., Koch, G., Strom, B. L., Guess, H. A., & Hartzema, A. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117563 · Cited by 352
USE OF MEDICAID DATA FOR PHARMACOEPIDEMIOLOGY
RAY, W. A., & GRIFFIN, M. R. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115198 · Cited by 315
Self-citationDrug‐ and non‐drug‐associated QT interval prolongation
Van Noord, C., Eijgelsheim, M., & Stricker, B. H. C. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03660.x · Cited by 264
Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death
Straus, S. M. J. M., Sturkenboom, M. C. J. M., Bleumink, G. S., Dieleman, J. P., Lei, J. V. D., Graeff, P. A. D., Kingma, J. H., & Stricker, B. H. C. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi312 · Cited by 260
Use of Azithromycin and Death from Cardiovascular Causes
Svanström, H., Pasternak, B., & Hviid, A. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300799 · Cited by 254
QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
De Ponti, F., Poluzzi, E., & Montanaro, N. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050714 · Cited by 240
Antimicrobial-Associated QT Interval Prolongation: Pointes of Interest
Goldstein, E. J. C., Owens, R. C., & Nolin, T. D. (2006) · Clinical Infectious Diseases · doi:10.1086/508873 · Cited by 231
Cardiac Actions of Erythromycin: Influence of Female Sex
Drici, M.-D., Knollmann, B. C., Wang, W.-X., & Woosley, R. L. (1998) · JAMA · doi:10.1001/jama.280.20.1774 · Cited by 194
Mortensen, E. M., Halm, E. A., Pugh, M. J., Copeland, L. A., Metersky, M., Fine, M. J., Johnson, C. S., Alvarez, C. A., Frei, C. R., Good, C., et al. (2014) · JAMA · doi:10.1001/jama.2014.4304 · Cited by 185
Stürmer, T., Schneeweiss, S., Brookhart, M. A., Rothman, K. J., Avorn, J., & Glynn, R. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi106 · Cited by 170
Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and Death
Rao, G. A., Mann, J. R., Shoaibi, A., Bennett, C. L., Nahhas, G. J., Sutton, S. S., Jacob, S., & Strayer, S. M. (2014) · The Annals of Family Medicine · doi:10.1370/afm.1601 · Cited by 158
Shaffer, D., Singer, S., Korvick, J. A., & Honig, P. K. (2002) · Clinical Infectious Diseases · doi:10.1086/340861 · Cited by 151
Comparing Sources of Drug Data about the Elderly
Johnson, R. E., & Vollmer, W. M. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb02872.x · Cited by 148
Poluzzi, E., Raschi, E., Moretti, U., & Ponti, F. D. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1746 · Cited by 138
Boyce, J. M., Medeiros, A. A., Papa, E. F., et al. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.1.73 · Cited by 106
Population-Based Studies of Adverse Drug Effects
Ray, W. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038145 · Cited by 106
Self-citationAn alternative approach to age adjustment of cancer survival rates
Brenner, H., Arndt, V., Gefeller, O., & Hakulinen, T. R. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.007 · Cited by 105
Kezerashvili, A., Khattak, H. K., Barsky, A. A., Nazari, R., & Fisher, J. D. (2007) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-007-9124-y · Cited by 99
Proarrhythmic Potential of Antimicrobial Agents
Simkó, J., Csilek, A., Karászi, J., & Lőrincz, I. (2008) · Infection · doi:10.1007/s15010-007-7211-8 · Cited by 82
Validation of Two Methods of Data Collection of Self-Reported Medicine Use Among the Elderly
Landry, J. A., Smyer, M. A., Tubman, J. G., Lago, D., Roberts, J. R., & Simonson, W. (1988) · The Gerontologist · doi:10.1093/geront/28.5.672 · Cited by 81
QT Prolongation Associated with Azithromycin/Amiodarone Combination
Samarendra, P., KUMARI, S., Evans, S. J., Sacchi, T. J., & Navarro, V. S. (2001) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2001.01572.x · Cited by 75
Adjustment for Multiple Cardiovascular Risk Factors Using a Summary Risk Score
Arbogast, P. G., Kaltenbach, L. A., Ding, H., & Ray, W. A. (2008) · Epidemiology · doi:10.1097/ede.0b013e31815be000 · Cited by 63
Self-citationAzithromycin-induced QT prolongation in elderly patient.
Russo, V., Puzio, G., & Siniscalchi, N. (2006) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 62
Polymorphic Ventricular Tachycardia with a Normal QT Interval Following Azithromycin
KIM, M. H., Berkowitz, C. E., & Trohman, R. G. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.50146.x · Cited by 57
Zambon, A., Friz, H. P., Contiero, P., & Corrao, G. (2009) · Drug Safety · doi:10.2165/00002018-200932020-00008 · Cited by 57
A case of QT-interval prolongation precipitated by azithromycin.
Matsunaga, N., Oki, Y., & Prigollini, A. (2003) · PubMed · Cited by 56
A computer case definition for sudden cardiac death
Chung, C. P., Murray, K. T., Stein, C. M., Hall, K., & Ray, W. A. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1888 · Cited by 52
Self-citationArellano‐Rodrigo, E., García, A., Mont, L., & Roqué, M. (2001) · Medicina Clínica · doi:10.1016/s0025-7753(01)72036-2 · Cited by 47
Tschida, S. J., Guay, D. R. P., Straka, R. J., Hoey, L. L., Johanning, R. J., & Vance‐Bryan, K. (1996) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1996.tb03650.x · Cited by 43
Long Q-T Syndrome Associated with Oral Erythromycin Used in Preoperative Bowel Preparation
Vogt, A. W., & Zollo, R. A. (1997) · Anesthesia & Analgesia · doi:10.1213/00000539-199711000-00010 · Cited by 21
Cited by
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
(2015) · Europace · doi:10.1093/europace/euv319 · Cited by 1,592
Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31180-6 · Cited by 1,200
RetractedBhimraj, A., Morgan, R. L., Shumaker, A. H., Lavergne, V., Baden, L., Cheng, V. C.-C., Edwards, K. M., Gandhi, R., Muller, W. J., O’Horo, J. C., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa478 · Cited by 1,033
International Consensus Statement on Allergy and Rhinology: Rhinosinusitis
Orlandi, R. R., Kingdom, T. T., Hwang, P. H., Smith, T. L., Alt, J. A., Baroody, F. M., Batra, P. S., Bernal‐Sprekelsen, M., Bhattacharyya, N., Chandra, R. K., et al. (2016) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21695 · Cited by 892
Metadata
- Authors
- Ray, W. A., Murray, K. T., Hall, K., Arbogast, P. G., & Stein, C. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-05-17
- Volume
- 366
- Issue
- 20
- Pages
- 1881-1890
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2119425860
- Cited by
- 954
- References
- 37
- FWCI
- 63.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.